Pro-Dex, Inc. (PDEX): Price and Financial Metrics
PDEX Price/Volume Stats
Current price | $17.08 | 52-week high | $22.99 |
Prev. close | $17.20 | 52-week low | $14.51 |
Day low | $17.08 | Volume | 499 |
Day high | $17.08 | Avg. volume | 8,746 |
50-day MA | $19.12 | Dividend yield | N/A |
200-day MA | $17.76 | Market Cap | 59.97M |
PDEX Stock Price Chart Interactive Chart >
PDEX Stock Summary
- PDEX has a market capitalization of $65,001,275 -- more than approximately just 16.39% of US stocks.
- Over the past twelve months, PDEX has reported earnings growth of 53.62%, putting it ahead of 82.92% of US stocks in our set.
- In terms of volatility of its share price, PDEX is more volatile than merely 17.15% of stocks we're observing.
- Stocks that are quantitatively similar to PDEX, based on their financial statements, market capitalization, and price volatility, are GTHX, HYPR, MRIN, GPRO, and WISA.
- PDEX's SEC filings can be seen here. And to visit PRO DEX INC's official web site, go to www.pro-dex.com.
PDEX Valuation Summary
- In comparison to the median Healthcare stock, PDEX's price/sales ratio is 69.05% lower, now standing at 1.3.
- PDEX's price/sales ratio has moved down 0.5 over the prior 243 months.
Below are key valuation metrics over time for PDEX.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
PDEX | 2023-12-29 | 1.3 | 2.0 | 11.5 | 9.3 |
PDEX | 2023-12-28 | 1.3 | 2.0 | 11.5 | 9.3 |
PDEX | 2023-12-27 | 1.3 | 2.0 | 11.4 | 9.2 |
PDEX | 2023-12-26 | 1.3 | 1.9 | 11.2 | 9.1 |
PDEX | 2023-12-22 | 1.3 | 2.0 | 11.3 | 9.2 |
PDEX | 2023-12-21 | 1.3 | 1.9 | 11.1 | 9.1 |
PDEX Growth Metrics
- Its 2 year revenue growth rate is now at 26.53%.
- Its 5 year cash and equivalents growth rate is now at 18.36%.
- Its 4 year price growth rate is now at 200.53%.
The table below shows PDEX's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 44.249 | -2.569 | 3.822 |
2022-09-30 | 43.14 | -0.656 | 3.868 |
2022-06-30 | 42.041 | -0.847 | 3.855 |
2022-03-31 | 38.861 | 5.157 | 3.304 |
2021-12-31 | 41.335 | 1.056 | 4.837 |
2021-09-30 | 39.427 | 1.511 | 4.249 |
PDEX's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- PDEX has a Quality Grade of C, ranking ahead of 55.91% of graded US stocks.
- PDEX's asset turnover comes in at 1.002 -- ranking 19th of 186 Medical Equipment stocks.
- APEN, ZBH, and BDX are the stocks whose asset turnover ratios are most correlated with PDEX.
The table below shows PDEX's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 1.002 | 0.357 | 0.150 |
2021-03-31 | 1.114 | 0.371 | 0.230 |
2020-12-31 | 1.136 | 0.372 | 0.237 |
2020-09-30 | 1.217 | 0.382 | 0.312 |
2020-06-30 | 1.201 | 0.377 | 0.316 |
2020-03-31 | 1.112 | 0.371 | 0.260 |
PDEX Price Target
For more insight on analysts targets of PDEX, see our PDEX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $39.00 | Average Broker Recommendation | 1.5 (Moderate Buy) |
Pro-Dex, Inc. (PDEX) Company Bio
Pro-Dex, Inc. products and distributes medical and dental equipment. The Company offers micro-air motors, surgical drivers, and precision air powered motors. Pro-Dex markets its products in the United States.
Latest PDEX News From Around the Web
Below are the latest news stories about PRO DEX INC that investors may wish to consider to help them evaluate PDEX as an investment opportunity.
3 Very Undervalued Stocks With Strong Growth ProspectsWhile the forward-looking mood for the equities sector may be pivoting in a positive direction, there are still opportunities among undervalued stocks with strong growth potential. |
Here’s Why You Should Consider Buying Pro-Dex (PDEX) SharesLong Cast Advisers, an investment management firm, released its third quarter 2023 investor letter, a copy of which can be downloaded here. In the third quarter of 2023, ending September 30, cumulative net returns stood at 8%. Year-to-date returns up to the quarter’s conclusion reached 20%. Since its inception in November 2015 through the end of […] |
Pro-Dex Inc (PDEX) Reports 8% Increase in Q1 Fiscal 2024 Net Sales, Despite Net Loss of $615,000Operating expenses decrease as gross profit rises by 24% YoY |
Pro-Dex, Inc. Announces Fiscal 2024 First Quarter ResultsIRVINE, CA / ACCESSWIRE / November 2, 2023 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2024 first quarter ended September 30, 2023. The Company also filed its Quarterly Report on Form 10-Q for the first quarter of ... |
Pro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day PodcastPHOENIX, AZ / ACCESSWIRE / October 26, 2023 / The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ:PDEX)("the Company"), a company that specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function ... |
PDEX Price Returns
1-mo | -3.28% |
3-mo | -1.44% |
6-mo | 8.03% |
1-year | -3.56% |
3-year | -31.65% |
5-year | 16.19% |
YTD | -2.51% |
2023 | 10.19% |
2022 | -31.50% |
2021 | -25.06% |
2020 | 76.47% |
2019 | 45.28% |
Continue Researching PDEX
Want to do more research on Pro Dex Inc's stock and its price? Try the links below:Pro Dex Inc (PDEX) Stock Price | Nasdaq
Pro Dex Inc (PDEX) Stock Quote, History and News - Yahoo Finance
Pro Dex Inc (PDEX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...